Assessing the Effectiveness of Hormonal Aromatase inhibitors (AI) Therapy in Hormone Receptor Positive Post-Menopausal Breast Cancer Patients: A Systematic Review
Bali Medical and Wellness Journal · 2024
DOI: 10.71341/bmwj.v1i2.7 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Bali Medical and Wellness Journal, 2024. Verfasst von Angki Perdiyana und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Endocrine therapy is a cornerstone in the treatment of breast cancer for patients who are hormone receptor-positive (HR+). Aromatase Inhibitors are a key option for managing HR+ breast cancer in postmenopausal women.
Objective
This study investigates the efficacy of Aromatase Inhibitors in postmenopausal women with HR+ breast cancer, focusing on their therapeutic benefits and associated risks.
Methods
A comprehensive literature review was conducted using the Cochrane, Google Scholar, PubMed, Science Direct, ClinicalTrials.gov, and Scopus databases, adhering to PRISMA guidelines. Study quality was evaluated using the Risk of Bias for Randomized Trials (RoB 2.0) tool.
Results
Aromatase Inhibitors function by inhibiting the aromatase enzyme, effectively reducing estrogen production. While they can be used with other therapies such as metformin or saracatinib, these combinations are not significantly more effective. Aromatase Inhibitors have been shown to enhance cognitive function and alleviate some depressive symptoms, although they may increase the risk of depression and anxiety in some patients.
Conclusion
Aromatase Inhibitors are an effective treatment for HR+ breast cancer in postmenopausal women. However, the potential psychological side effects, such as depression and anxiety, require careful management during therapy.
Zitieren
APA
Perdiyana, A., Lesmana, A., Sitompul, D. S. A., Wijayanti, F. A., Alrasyid, M. D., Wiguna, N. Y. R., Sutomo, T. N. S., Nugraha, D., & Fitriani, E. (2024). Assessing the Effectiveness of Hormonal Aromatase inhibitors (AI) Therapy in Hormone Receptor Positive Post-Menopausal Breast Cancer Patients: A Systematic Review. Bali Medical and Wellness Journal. https://doi.org/10.71341/bmwj.v1i2.7
Vancouver
Perdiyana A, Lesmana A, Sitompul DSA, Wijayanti FA, Alrasyid MD, Wiguna NYR, et al. Assessing the Effectiveness of Hormonal Aromatase inhibitors (AI) Therapy in Hormone Receptor Positive Post-Menopausal Breast Cancer Patients: A Systematic Review. Bali Medical and Wellness Journal. 2024. doi:10.71341/bmwj.v1i2.7
BibTeX
@article{Perdiyana2024,
author = {Perdiyana, Angki and Lesmana, Agri and Sitompul, Dea Syafira Alamsyah and Wijayanti, Fakhira Ayu and Alrasyid, Miko Dharma and Wiguna, Naufal Yafi Rais and Sutomo, Tharisa Novianti Syabania and Nugraha, Deity and Fitriani, Elies},
title = {Assessing the Effectiveness of Hormonal Aromatase inhibitors (AI) Therapy in Hormone Receptor Positive Post-Menopausal Breast Cancer Patients: A Systematic Review},
journal = {Bali Medical and Wellness Journal},
year = {2024},
doi = {10.71341/bmwj.v1i2.7}
}
EUVIMED